To improve liposomal gene transfer we investigated the influence of membrane-interacting alkylphospholipids (APLs) on gene transfer efficiency in vitro and in vivo using the LacZ reporter gene and the cytosine deaminase (CD) suicide gene. Liposomes were first optimized concerning the kind and amount of APL and the additional liposome components. Thus, an up to 270% increase in the transfer efficiency of the LacZ gene into HCT15 and HCT116 human colon carcinoma cells could be obtained in vitro compared to lipofectin-mediated transfection by using a lipoplex consisting of tetradecylphosphocholine/dimethyldioctadecylamine/ cholesterol/dioleylphosphoethanolamine-liposomes and the pSV40-bGal-plasmid. The in vivo experiments revealed that alkylphospholipid-lipoplexes (APL-LPs) were similarly effective in the transfer of the LacZ gene into colon carcinoma as formulations consisting of lipofectin. Using the CD-gene in combination with APL-LPs resulted in a significantly stronger inhibition of C26 colon carcinoma growth compared to lipofectin-mediated gene transfer following treatment of mice with the prodrug 5-fluorocytosine. The results of this study demonstrate for the first time that the utilization of membrane-active APLs as component of the liposomal part of lipoplexes enhances the efficacy of gene therapy in vitro and in vivo.
T he development of a safe and efficient procedure for delivery of genetic material into cells is essential for successful gene therapy. A broad spectrum of viral and nonviral transfer technologies has been developed and is currently studied and utilized at preclinical and also clinical level. Despite of their high transfer efficiency, viral vector systems are still associated with safety concerns and therefore many efforts are focusing on the development of nonviral transfer technologies. Among those, lipofection evolved into a well-established technique providing safety of gene transfer associated with reasonable but transient transfer efficiency in vitro and in vivo. 1 Particularly, cationic lipid-nucleic acid complexes (lipoplexes) are among the most efficient nonviral vehicles to introduce DNA into the desired target cells. Despite the numerous encouraging studies for successful use of lipoplexes, efforts are still being made to improve currently available lipoplex formulations for enhanced DNA transfer into cells. 2, 3 In this context, many different cationic liposomal formulations have been generated for the utilization as lipid part of lipoplexes and extensively tested to improve gene transfer in vitro and in vivo and to minimize toxicity. [4] [5] [6] [7] [8] [9] Most studies have been performed mainly on the synthesis and investigation of new cationic lipids for DNA complexing [10] [11] [12] [13] used either alone or combined with one particular helper lipid from only a small panel of helper lipids. Dioleylphosphatidyl-ethanolamine (DOPE) is such a highly efficient helper lipid which is believed to enhance the fusion process of the lipoplex with the endosomal membrane. Another compound used as helper lipid is CH, which seems to be important for altering the liposomal membrane properties preventing the absorption of serum proteins on the liposomal surface. 14, 15 However, despite the great versatility of different lipoplexes for the gene delivery, alkyl phospholipids (APLs) have so far not been employed for such gene transfer systems.
APLs are known to be compounds acting effectively at the cellular membrane level 16 with even anticancer therapeutic potential. Therefore, inclusion of APLs in liposomal formulations for gene delivery systems could have a positive impact on transfer efficiency and improved gene therapy.
This prompted us to determine the gene transfer efficiency of liposomes prepared from APLs (Fig 1) , in combination with the cationic compound dimethyldioctadecylammonium bromide (DDAB) and, most frequently, a mixture of cholesterol (CH) and DOPE, whereas some liposomes were prepared which contain either CH or DOPE in addition to APL and DDAB.
APLs were selected because it is known that these particular cancerostatic lipids interact at the cell membrane level. 17 They have amphiphilic, detergent-like properties and the use of APL as part of the liposomal bilayer alters the membrane organization. Related to their detergent-like properties, it could be expected that APL displays a greater fusiogenic effect than the double-chain lipid DOPE or its O-alkylated derivative. 18 Thus, it can be assumed that in lipoplexes APL may promote the transmembrane transport of the plasmidliposome complex into the target cell.
Therefore, the effect of chain length, head group and saturation using different APLs, as well as the influence of cholesterol and charge ratio within the lipoplexes on the gene transfer was investigated in vitro and in vivo. The in vitro transfection levels were quantified at the reporter gene product level by measuring the b-galactosidase (LacZ) enzyme activity. The most efficient APL-liposome formulation was then tested for the in vivo gene transfer of the cytosine deaminase (CD)-gene for its therapeutic potential in tumor gene therapy.
Methods

Preparation of liposomes
Liposomes L1-L19 were prepared consisting of APL (ASTA Medica, Frankfurt, Germany), a cationic lipid (DDAB, from Fluka, Buchs, Switzerland), and in some formulations additionally of cholesterol and/or DOPE (both from Sigma-Aldrich, Deisenhofen, Germany) by the lipid film/hydration technique. The individual compositions are indicated in Table 1 . The films were prepared from stock solutions of the lipids in a roundbottomed flask by rotary evaporation and high vacuum drying, which were then hydrated with a glucose solution (5%, w/v) to a final concentration of 2-10 mM of APL. Multilamellar vesicles were obtained by 12 hours of shaking and were then extruded repeatedly through polycarbonate membranes of 200 nm pore size using a LiposoFASTt Basic system (Avestin, Ottawa, Canada) to prepare homogeneous suspensions of LUVET with a mean diameter of about 200 nm and a polydispersity index of 0.3 or smaller as determined by dynamic lightscattering measurements with a Coulter Counter N4 plus (Coulter Electronics, Hialeah).
The concentration of the liposomes is given as total amount of lipids within the vesicle, which was calculated based on the actual amount of APL after determination by HPTLC as described previously. 19 
Lipoplex formation
Defined amounts of liposomes L1-L19 (for abbreviation and composition see Table 1 ) between 5 and 0.5 mg total lipid were resuspended in 190 ml Dulbecco's MEM without serum. Lipofectin (used as control in all transfection experiments) was always used in an amount of 2.5 mg/ 190 ml (media and transfection reagent were from Gibco/ Life Technology GmbH, Karlsruhe, Germany).
The plasmid pSV40-bGal (Promega, Marburg, Germany) was amplified with a Jetstar Plasmid MAXI kit 20 (Genomed, Bad Oyenhausen, Germany). It was serially diluted to concentrations between 2 and 0.06 mg/10 ml. A Alkylphospholipid vesicle mediated gene transfer R Zeisig et al total of 10 ml of the individual plasmid solution was added to the specific liposome dilution, shaken for 10 seconds and allowed to mature for 50 minutes at room temperature to obtain the lipoplexes. Lipoplexes L9-LP and lipofectin-lipoplex (LF-LP) for animal experiments were prepared in a modified procedure as follows: Liposomes LF or L9 (for composition see Table 1 ) were extruded as described above or sonicated for 4 minutes 2 times with 5-minute interruption using a Branson sonifier to obtain mainly small unilamellar vesicles which were then diluted to a final concentration of 10 mg total lipid/ml. Appropriate volumes were then given to the pSV40-bGal plasmid to obtain a mass ratio of 5:1 or 10:1. After maturation at room temperature for 45 minutes, lipoplexes were used for mice treatment.
LacZ transfection experiments in vitro
Transfection experiments were performed using the human colorectal carcinoma cell lines HCT116 20 and HCT15. 21 Cells were seeded at a density of 2 Â 10 4 cells/ well in a microtiter plate 1 day before the transfection experiment. Cells were washed once with serum free Dulbecco's MEM before the matured lipoplexes were added to the cells. After 4 hours, FCS was added to obtain a final serum concentration of 10% for further 48 hours incubation. Then the supernatant was removed from each well and 200 ml ONPG-solution (Roche, Mannheim, Germany, 1 mg/ml) 22 was added to each well. b-galactosidase (LacZ) activity, as marker of transfection efficiency, was determined in the colorimetric assay by absorbency measurements at 405 nm with a spectrophotometer Rainbow (Tecan SLT, Crailshaim, Germany) every hour during the following 8 hours.
Transfection efficiency is expressed as an increase in LacZ-activity in comparison to the transfection obtained with the most effective LF-LP in each individual experiment, which was set to 100%. All data given represent the mean of the three independently performed experiments, each done in duplicate.
MTT-cytotoxicity assay
Transfection of cells was carried out as described above. After 48 hours of incubation with the lipoplexes, the supernatant was removed, cells were washed once with PBS and then incubated with 200 ml RPMI containing MTT (Sigma-Aldrich, Deisenhofen, Germany; 100 mg/ ml). After 4 hours, 170 ml of the supernatant was carefully removed and the residual formazan crystals were dissolved in 1 N HCl/isopropanol solution (4/96, v/v). The colorimetric measurement was performed at 540 nm using the spectrophotometer Rainbow (Tecan SLT, Crailshaim, Germany). Cell viability is given as viability of treated cells in percent compared to control cells treated similarly but without any lipoplexes.
Intratumoral LacZ-activity after reporter gene transfer
Male NMRI nu/nu mice (own breeding facility) bearing the HCT116 colon carcinoma were injected intratumorally each with L9-LPs or LF-LPs containing 30 mg of the pSV40-bGal plasmid. After 2, 3 and 8 days animals were killed and tumors shock frozen. After homogenization of the tumor and centrifugation at 41C, the supernatants were used to determine the enzymatic activity similarly to the cell culture experiment described above. The quantitative determination of LacZ was performed using a bgalactosidase-specific ELISA (Roche, Mannheim, Germany) as described earlier. 23 The results of both assays were normalized to the protein amount of each tumor lysate obtained after protein determination using the Coomassie Plus Protein Assay Reagent (Pierce, Rockford, IL). Each determination was performed in duplicate and the results represent the mean7SD for five tumors.
For detection of reporter gene expression, animals were killed and tumors were removed for preparation of cryosections. The cryosections (7 mm) were fixed in 2% formaldehyde for 10 minutes at 41C and rinsed twice with ice-cold PBS. The slides were then placed in quadriPERM plus (Heraeus Instruments, Osterode, Germany) chambers and covered with 3 ml X-Gal mix (350 ml X-Gal (5-Bromo-4-chloro-3-indolyl-b-d-galactoside) stock solution of 20 mg X-Gal in 1 ml dimethylformamide; 7 ml 1.1 mM MgCl 2 ; 0.5 ml 50 mM K 3 Fe(CN) 6 and 0.5 ml K 4 Fe(CN) 6 ) for b-galactosidase detection. The cryosections were incubated for at least 24 hours at 371C and then covered in Faramount aqueous mounting medium (Dako, Carpinteria, CA).
Suicide gene transfer in vivo
C26 human colon carcinoma cells (1 Â 10 5 ) were transplanted subcutaneously along the right flank of 6-to 8-week-old female Balb/c mice at day 0. The animals were staged for 2-3 weeks to allow the development of tumors with a size of approximately 6 Â 6 mm 2 . Tumor-bearing mice were randomized for the studies and six mice used for each group.
For intratumoral transduction of tumors with LF-CD LP or L9-CD LP, animals were injected once at day 7 with lipoplexes containing 30 mg pCMV/CD-1 plasmid-DNA/mouse. The tumor-bearing control animals received 0.9% sodium chloride solution or 30 mg of the naked pCMV/CD-1 plasmid at the same time in the same volume.
To evaluate the therapeutic efficiency of the transduced CD-gene in the C26 tumors, animals were treated i.p. at days 10-17 with 500 mg/kg 5-fluorocytosine (5-FC). Tumor size was measured in two dimensions. Tumor volumes were calculated for the respective control and treated animals as (width 2 Â length)/2 and expressed as mean tumor volume (MTV) in cm 3 .
Statistics
Statistical analysis of in vitro assays was performed with the unpaired Student's t-test. Differences were considered to be significant at Po.05. For the analysis of in vivo data the U-test of Mann and Whitney was used.
Results
Lipoplex formation
The APL used for the generation of 19 different liposomes varied in chain length, saturation of the chain and in the type of the head group (Fig 1) . The amount of the APL was modified between 3.2 mol% (for example L9) and 33.3 mol% (L10) of all liposomal components. The individual compositions of the liposomes, indicated as L1-L19 are summarized in Table 1 . Complexes of liposomes and plasmid DNA are indicated consequently as lipoplexes in accordance to Felgner 11 (where Ln-LP refers to the lipoplex prepared from liposome Ln).
Influence of the lipoplex components on the transfection efficiency
The two human colon carcinoma cell lines HCT15 and HCT116 were tested for their susceptibility to lipofection of the reporter gene for b-galactosidase (LacZ), which converts 2-nitrophenyl-b-galactopyranosid into the yellow nitrophenol derivative. Transfection of the HCT116 cells resulted in a higher LacZ enzymatic activity than of HCT15 cells. It was found that a maximum transfection was always observed within 8 hours for all alkylphospholipid-lipoplexes (APL-LPs) and LF-LPs.
Transfection efficiency was determined for lipoplexes consisting of 2.5, 2, 1.5 or 1.0 mg liposomes in combination with individual amounts of plasmid DNA between 2.0 and 0.06 mg. In all experiments the lipofection efficiency was compared to LF-LP-mediated gene transfer and expressed as percentage of the highest LF-LP transfection rate. As a consequence of this, the ratio between the positive charge equivalents/negative charge equivalents (P/N) of APL-LP varied depending on the liposome composition in the range between 0.33 (L10-LP) and 2.25 (L15-LP, L17-LP).
First, it was found that the efficiency of lipofection in vitro was enhanced with an increase of the amount of the positively charged liposomes within the lipoplexes from 1.0 to 2.5 mg/well up to 300% for both cell lines (data not shown). On the other hand, the strongest enhancement of transfection did not always correlate with the highest amount of the plasmid DNA supplied to the cells. Depending on the kind of lipoplexes used, it varied for the most efficient lipoplexes between 0.3870.13 mg DNA/ well (L15) and 1.3370.48 mg DNA/well (L10), whereas the highest activity of LF-LP was achieved by a combination of 0.5 mg plasmid and 2.5 mg lipofectin. This LF-LP was calculated to have a charge ratio of 1.18. Figure 2 summarizes the influence of APL chain length on the lipofection efficiency for HCT116 colon carcinoma cell lines including results for comparable LP formulaAlkylphospholipid vesicle mediated gene transfer R Zeisig et al tions with tetradecylphosphocholine (TPC), HPC or OPC consisting of 2.5 mg liposomes and 0.5 mg plasmid with a P/N of 1.76. In addition, results are shown which reflect the best transfection efficiency obtained with these lipoplexes independent on the composition, and thus also with different P/N values. L13-LP and L15-LP containing hexadecylphosphocholine (HPC, C16-chain length) or octadecylphosphocholine (OPC, C18 chain length) respectively, produced only a weak transfection, whereas L9-LP with additional TPC caused a significantly higher transfection rate (Fig 2) . These findings were independent on the type of results which were compared (for similar compositions or formulations resulting in maximum transfection). The addition of 2 molar parts of TPC to liposomes consisting of DDAB/CH/DOPE (L1; 40/10/ 10 mol/mol) did enhance the transfection efficiency (compared to lipofectin) from 178% (L1-LP) to more than 250% (L9-LP; Table 2 ). An additional increase of the TPC amount did not further enhance transfer efficiency, but rather decreased it for the HCT116 cell line.
The effect of DDAB was found to be dependent on the charge ratio P/N expressing the total charge of the final complex but not on the amount of the charged compound in the lipoplex. An increase of transfection was found from L2-LP to L6-LP to L3-LP to L9-LP (Fig 3) , which corresponds P/N of 0.90, 1.33, 1.59 and 1.76, respectively for lipoplexes with 2.5 mg liposomes and 0.5 mg plasmid.
The steroid CH as part of the liposomal membrane had only a minor effect on the transfection, but stabilized the membrane in the presence of APLs. 24 
Toxicity of lipoplexes in vitro
Since cytotoxicity is a well-known direct side effect of lipoplexes, toxic effects of our formulations were determined using the MTT-cytotoxicity assay 25 to quantify the cell viability after lipoplex treatment, which was similar to the transfection protocol. A clear influence of the plasmid amount on the cytotoxicity was found if complexed with 2.5 mg positively charged liposomes (Fig 4) : the lower the amount of the plasmid DNA was, and thus as higher the P/N ratio was, the lower was the viability of treated cells. The toxicity of the APL-LPs including also the L9-LP with the highest transfection effect was always higher as or comparable to LF-LP.
LacZ gene transfer in vivo
First we followed the LacZ expression in the tumor tissues by X-Gal staining of tumor cryosections (Fig 5) . We observed localized presence of this reporter gene after intratumoral injection of L9-LP and LF-LP. To quantify this effect we determined additionally the activity and the amount of the LacZ enzyme b-galactosidase after the reporter gene transfer into the HCT116 tumor in comparison to LF-LP. Enzyme activity and enzyme amount were determined in the cell lysate obtained from treated tumors. The results are summarized in Figure 6 and demonstrate that the enzyme activity is measurable after gene transfer with both the L9-LP (P/N: 1.76) and the LF-LP (P/N: 1.18). However, the L9-LP was in this particular experiment significantly more efficient than the LF-LP (Fig 6) . Figure 3 Influence of DDAB in the lipoplexes on transfection efficiency. Lipoplexes (for details see Table 2 ) composed of DDAB/ TPC/CH/DOPE-liposomes (2.5 mg) with the indicated amount of DDAB/well and used to complex the plasmid DNA. Transfection of the cell lines HCT15 and HCT116 is expressed as increase in transfection rate in% (mean7SD; n ¼ 4) obtained with lipoplexes with the indicated liposomes compared to the maximum transfection rate obtained with LF-LPs (defined as 100%).
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Therapeutic effect of lipoplex-mediated intratumoral CD-gene transfer in vivo
The previous in vivo experiments revealed the effectiveness of APL-LPs for intratumoral reporter gene transfer.
Based on these findings, gene transfer was performed to evaluate the use of APL-LPs for the introduction of the CD suicide gene in a gene therapeutic approach. For this, the C26 human colon carcinoma model was used, since both HCT116 and HCT15, are not sensitive towards 5-fluorouracil (5-FU) treatment and are therefore not suited for this suicide therapy. 26 The C26 tumorbearing animals received a single dose of the L9-CD LP; the LF-CD LP with 30 mg plasmid/mouse or controls (physiological NaCl or naked DNA) intratumorally. The effect on tumor growth was determined after the gene transfer and during treatment with 5-FC.
First, we found that lipoplexes consisting of the L9-liposomes and the plasmid in an amount ratio of 1:5 (P/N 1.76) exerted no or only a weak effect on tumor growth (data not shown), whereas treatment with L9-CD LP in a 10:1 ratio (P/N 3.2) had significant therapeutic activities (Fig 7) . We observed a significant tumor growth reduction of 35% in comparison to the untreated control group (Po.05) between days 13 and 17. LF-CD LP as well as the additional controls were without any growth inhibitory effect.
In a second experiment (data not shown), the L9-CD LP with a P/N of 3. Table 2 ) were used to complex different amounts of DNA. HCT116 cells were incubated with these lipoplexes for 48 hours before viability was determined using the MTT-assay as described in Methods. Given is the mean viability in percent compared to control cells treated similarly but without lipoplex incubation. Data represent the mean of two independent experiments, each performed in triplicate. Standard deviation is indicated only for selected data to keep the graph readable.
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Discussion
Until now, no investigations have been performed to use APLs for the improvement of the transfection efficiency. APLs are known to be cancerostatic-active lipids 27-31 of a relatively simple structure, consisting only of the hydrophilic head group which is directly linked to a single hydrophobic alkyl chain (Fig 1) . Thus, these lipids have surfactant-like properties and induce leaks or holes in the cellular membrane. 32 Taking into account that the transmembrane transport of the liposome-DNA complex is the necessary first step in the transfection cascade at the cellular level, it was assumed that APLs could facilitate the entrance of the liposome-DNA complex and therefore enhance the transfection process.
To proof this hypothesis, we selected APLs with different lengths of the alkyl chain and with three different head groups (Table 1 ). The APL were combined with the cationic amphiphilic DDAB and usually with DOPE and/or CH to form liposomes (Table 2) . These liposomes were then used to complex plasmids encoding the reporter LacZ gene for quantification of transfer efficiency or the CD suicide gene for tumoricidal purposes. Lipofectin was selected as control transfection reagent because it is still the most widely used, wellknown and commercially available reagent. Figure 6 Amount and activity of the b-galactosidase enzyme after gene transfection of the pSV40-bGal plasmid in vivo. HCT116 colon carcinoma-bearing male NMRI nu/nu mice were injected intratumorally each with lipoplexes L9-LP or LF-LP and tumors isolated. After homogenization and cell lysis the enzymatic activity, amount of enzyme and total cellular protein were determined as described in Methods. Given is the enzymatic activity in 0.1 mU/mg protein and the enzyme amount/total protein for three tumors as the mean7SD for three determinations. *Significantly different to LF-LP-treated group (Po.05). 
LF-LP
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The present study was aiming at three goals:
to optimize the APL-LPs concerning the transfection efficiency in vitro using the LacZ-gene; to select and test the most efficient APL-LP for the in vivo gene transfer of the LacZ reporter gene; and to employ the most efficient APL-LP for the transfection of the CD-suicide plasmid to tumor-bearing mice.
The optimization of the APL-LPs revealed that it is necessary to combine a low portion of a short-chain APL with a charged compound, cholesterol and DOPE. The best transfection with a three-fold increase compared to LF-LP was obtained if APL-liposomes, containing the short-chain APL TPC (e.g. L9 liposomes), were used for gene transfer. Taking into account that neither the head group nor the introduction of a double bound into the alkyl chain had any effect on the transfection rate (data not shown), it can be concluded that the general molecular shape of the APL, especially the space requirement of the alkyl group compared to that of the head group, is responsible for differences in the ordering structure of the membrane. As a consequence, these changes may finally influence the phase behavior and the structure of lipoplexes prepared from these liposomes concerning the transfection efficiency. In addition, an increase in the hydrophilicity caused by a shorter chain length may also contribute to a higher disorder of the liposomal membrane which facilitate the exchange of, for example TPC, into the cellular membrane.
Another important effect resulted from the ratio between the positive and negative charge equivalents (P/ N) of the cationic liposome and the plasmid, respectively. The most efficient combination of lipofectin and the LacZ plasmid (LF-LP with 2.5 mg LF and 0.5 mg plasmid) had a P/N ratio of 1,18. On the other hand, the highest transfection with APL-LPs were obtained in vitro with a slightly higher P/N between 1.5 and 2 (L9-LP: 1.69), whereas L9-LP with a P/N ratio of 3.2 was much more effective in vivo. This is consistent with the findings of several other groups [33] [34] [35] [36] [37] [38] indicating that a slight positive charge (charge ratio between 1 and 2) supports the binding of the complex to the (negatively charged) cell membrane, whereas nucleic acid compaction rather than surface charge was critical for an efficient nuclear trafficking. 39 On the other hand, some reports describe other ratios for more efficient complexes, 10, 38, [40] [41] [42] which indicated that the charge ratio is not the only factor responsible for the transfection efficacy. The character of the liposome, the ordering structure of the lipoplex as well as the targeted cell line are additional important factors. 40 We further evaluated the combination of APL and DDAB with the helper lipids DOPE and/or CH and found the same influences on transfer efficiency as it could be expected from earlier studies. 1, 7, 43 In agreement with several other studies focusing on the role of DOPE on transfection enhancement 44 we also found that DOPE should be present in the lipoplex to obtain a good transfection (data not shown). The inclusion of cholesterol into the APL-liposome formulations had no effect on the transfection efficiency under the conditions used in this study, but stabilizes the liposomal membrane. TPC alone is not able to form liposomes and the presence of DDAB should further disturb a formation of a regular bilayer.
Toxicity of liposomal transfection reagents is a serious problem, usually caused by the lipid used to induce the positive charge of the lipoplex. The viability of the treated cells was in the range between 90 and 40%, depending on the composition of the liposomes. Cytotoxicity correlated directly with the amount of DDAB and indirectly with the amount of DNA within the lipoplex: the lower the amount of DNA that is complexed by a certain amount of liposomes, the higher is the resulting total positive charge associated with cytotoxicity. Therefore, the increase in transfection rates correlated much better with the P/N than with the molar amount of DDAB in the liposomes. Another interesting aspect is that even the most cytotoxic lipoplexes were found to induce the highest transfection, as it was also described earlier for other transfection systems. 13 Thus, toxicity per se is not a disadvantage, but could support the killing for example of tumor cells by a combined action of a cytotoxic effect and an enhanced transfection of the remaining resisting cells. This is especially important for an intratumoral treatment where the additive effect can enhance the antitumor effect, whereas an unspecific toxicity after intravenous injection has still to be proven.
In transfection experiments performed to follow the expression of the LacZ reporter gene in vivo we found a significant advantage of the L9-LP over LF-LP-mediated lipofection. This prompted us to use this APL-LP in an in vivo therapeutic gene approach.
In these experiments, the CD gene was transfected intratumorally into C26-bearing animals to exploit the CD enzyme activity, which converts the nontoxic prodrug 5-FC into the cytotoxic metabolite 5-FU. Since this suicide system is not suited for the relatively 5-FU insensitive HCT116 xenograft model, the C26 human colon carcinoma model was used, which is known to be sensitive to 5-FU. In CD-gene transduced animals a significantly delayed tumor growth between days 11 and 17 was seen, if L9-LP was used, whereas no therapeutic effect with LF-LPs could be observed. However, the fact that the APL-LPtreated tumors started to regrow after day 17, indicates that the treatment schedule still has to be improved to achieve a long-term therapeutic antitumor effect.
In conclusion, the results of this study demonstrate for the first time the possibility to use the membrane-active APLs as novel helper lipids in lipoplexes employed for in vitro and in vivo gene transfer. These lipids are significantly different from all other known helper lipids in cationic liposomal formulations for DNA complexation. The best transfection efficiency in comparison to commonly used transfection kits was obtained if a short chain APL-like TPC was included in a small amount into the liposome formulation. This could be demonstrated for the transfection of a reporter gene as well as for the suicide gene. Further investigations to optimize the treatment schedule and to evaluate additional routes of gene transfection in vivo are in progress.
